The ethics of participant-led biomedical research

Nature Biotechnology

Volumn 31, Issue 9, 2013, Pages 786-787

  Vayena, Effy ^a   Tasioulas, John ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ALGORITHM; AMYOTROPHIC LATERAL SCLEROSIS; CROWDSOURCING; EMPOWERMENT; HUMAN; INSTITUTIONAL REVIEW; LETTER; MEDICAL ETHICS; MEDICAL RESEARCH; MICROBIOME; PRIORITY JOURNAL;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; ETHICS, RESEARCH; HUMANS; PATIENTS; RESEARCH PERSONNEL;

EID: 84884153822     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2692     Document Type: Letter

References (10)

1. Wicks, P. et al. Nat. Biotechnol. 29, 411-414 (2011).
2. Brownstein, C.A. et al. Nat. Biotechnol. 27, 888-890 (2009).
3. Kaye, J. et al. Nat. Rev. Genet. 13, 371-376 (2012).
4. Goldacre, B. Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients (Fourth Estate, New York, 2013).
5. P ereira, T.V. et al. J. Am. Med. Assoc. 308, 1676-1684 (2012).
6. Janssens, A.C.J.W. &Kraft, P. PLoS Med. 9, e1001328 (2012).
7. R ichman, J. &Apte, Z. Crowdfunding and IRBs: the case of uBiome. Sci. Am. (22 July 2013). http://blogs. scientificamerican.com/guest-blog/2013/ 07/22/crowdfunding-and-irbs-the-case-of-ubiome/
8. S tone, J. uBiome: ethical lapses or not? Sci. Am. (25 July 2013). http://blogs.scientificamerican.com/molecules-to-medicine/2013/07/25/ ubiome-ethicallapse-or-not/
9. Vayena, E. &Tasioulas, J. PLoS Med. 10, e1001402 (2013).
10. Swan, M. J. Pers. Med. 2, 93-118 (2012).